Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care modelsSAN ANTONIO, Dec. 2, 2025 /PRNewswire/…
NULISAseqâ„¢ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…